1. Home
  2. KVUE vs GEHC Comparison

KVUE vs GEHC Comparison

Compare KVUE & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.33

Market Cap

39.9B

ML Signal

HOLD

Logo GE HealthCare Technologies Inc.

GEHC

GE HealthCare Technologies Inc.

HOLD

Current Price

$83.98

Market Cap

33.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVUE
GEHC
Founded
2022
1892
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Computer Software: Prepackaged Software
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
39.9B
33.1B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
KVUE
GEHC
Price
$17.33
$83.98
Analyst Decision
Buy
Buy
Analyst Count
13
9
Target Price
$20.31
$86.67
AVG Volume (30 Days)
37.7M
4.2M
Earning Date
11-03-2025
10-29-2025
Dividend Yield
4.79%
0.17%
EPS Growth
35.31
32.35
EPS
0.75
4.83
Revenue
$15,006,000,000.00
$20,246,000,000.00
Revenue This Year
N/A
$6.33
Revenue Next Year
$2.81
$4.38
P/E Ratio
$23.18
$17.38
Revenue Growth
N/A
3.51
52 Week Low
$14.02
$57.65
52 Week High
$25.17
$94.80

Technical Indicators

Market Signals
Indicator
KVUE
GEHC
Relative Strength Index (RSI) 60.90 61.45
Support Level $16.70 $82.51
Resistance Level $17.59 $86.19
Average True Range (ATR) 0.31 2.29
MACD 0.03 0.48
Stochastic Oscillator 76.29 77.18

Price Performance

Historical Comparison
KVUE
GEHC

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Share on Social Networks: